Literature DB >> 32566159

COVID-19 in Egypt: Uncovered figures or a different situation?

Mohammed A Medhat1, Mohamed El Kassas2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32566159      PMCID: PMC7303805          DOI: 10.7189/jogh.10.010368

Source DB:  PubMed          Journal:  J Glob Health        ISSN: 2047-2978            Impact factor:   4.413


× No keyword cloud information.
The newly discovered Coronavirus, recently named SARS-CoV-2, emerged from The newly discovered Coronavirus, recently named SARS-CoV-2, which emerged from Wuhan, China, resulted in a pandemic public health emergencies. As of April 19, 2020, Egypt has reported 3144 cases of COVID-19 and 239 deaths. However, some reports claimed that these figures are underrated, especially with the documentation of several exported cases from Egypt to other countries, and that the burden of COVID-19 infection in Egypt, therefore, might be considerably more significant than reported. Meanwhile, Egypt has established a convincing model of care in order to combat the COVID-19 epidemic under the supervision of the World Health Organization. In this report, we tried to highlight the situation of COVID-19 infection in Egypt, the possible causes of the relatively lower rates of infection in the country like high temperature, humidity, early use of BCG vaccination, and possibly a different viral subtype. This is besides detailing the state and preventive measures taken to face this epidemic by the country. The newly discovered Coronavirus, recently named SARS-CoV-2 (COVID-19), emerged from Wuhan, China, resulting in a pandemic public health emergencies. Recent epidemiological data shows that there are more than 2 million people were infected with SARS-CoV-2 with a mortality rate of >6.7% [1]. In an earlier report, Egypt had the highest risk of SARS-CoV-2 infection importation among African countries [2]. On February 14, 2020, Egypt announced the first case of COVID-19 in Africa and needed about three months to record 10 000 cases, which was almost double the time that Italy and the USA took to reach the same number of cases. Tuite et al. proposed an estimation of the outbreak size of 19310 cases of COVID-19 (95% confidence interval (CI) = 6270-45 070) in Egypt based on diagnosed cases coming from Egypt in different countries [3]. This data does not coop with what is announced by the Egyptian Ministry of Health (MOH), and thus a big question was aroused; Does Egypt have uncovered data about the real number of COVID-19 cases?

EGYPTIAN STATE EFFORTS TO CONTROL COVID-19 INFECTION

Since the announcement of the first case of the SARS-CoV-2 case in Egypt, the government started multidisciplinary national coordination between different ministries. In February, they decided that there is no need to stop close airport travels, schools, or universities at this stage. Instead, Egypt started to examine all tourists coming to Egypt and to trace them for the development of fever or respiratory symptoms after arrival. Egypt discovered cases of COVID-19 in a cruise ship in Luxor, and subsequently, the authorities prevented the onboard passengers and the crew from leaving the ship and sent a medical team to take care of them. On March 8, Egypt announced that a 60 year-old German tourist died in the touristic town Hurghada, Egypt, and this was the first German fatality from the virus. The escalation in the number of cases by the middle of March to be >100 cases prompted the government to take more strict arrangements. Egypt suspended schools and universities for one month and encouraged electronic distance learning. Also, Egypt imposed a curfew from 7 pm until 6 am, during which all shops and markets are closed from 5 pm to 6 pm and are subjected to a complete shutdown on Fridays and Saturdays. Besides, all means of public and private transportation are suspended during curfew hours. Flight into or out of Egypt were also suspended in an attempt to reduce the risk of importing infection. All sports and many social activities were also banned to prevent the spread of COVID-19.

HEALTH MEASURES TO CONTROL INFECTION

Egypt abandoned individual hospitals in every governate to be assigned as quarantine hospitals for COVID-19 patients. Egyptian MOH decided to relay on a medical team composed of different specialties (Pulmonology, Internal Medicine, Tropical Medicine, Infectious Diseases, Intensive care, Radiology, Clinical Pathology, Clinical Pharmacy, and Infection control) to take care of the inpatients in these quarantine hospitals. Each medical team stays in the hospital for 14 days, then all team members should be tested for SARS-CoV-2 through nasopharyngeal swabs, and infection negative team members are released for home self-isolation for another 14 days. Positive swab doctors (if any), are to stay in the quarantine hospital to get medical care. Egyptian MOH issued a standardized guide for the diagnosis and management of COVID-19. According to this protocol, patients with COVID-19 infection are classified on clinical bases into mild, moderate, severe, and critical cases. Mild cases are patients in whom clinical symptoms are mild, with no signs of pneumonia in chest imaging. Moderate cases are those complaining of COVID-19 symptoms such as fever or manifestations of chest disease, or imaging results indicative of pneumonia. Severe cases are patients who meet any of the following criteria; (a) respiratory rate >30 breaths/min, (b) oxygen saturations <93% at a rest state, (c) arterial partial pressure of oxygen (PaO2)/ Fraction of inspired oxygen (FiO2)<300 mm Hg, or (d) patients with more than 50% lesions progression within 24 to 48 hours in lung imaging. Finally, critical patients are those who are meeting any of the following criteria; (a) occurrence of respiratory failure requiring mechanical ventilation, or (b) the presence of shock; other organ failures that require monitoring and treatment in the ICU. The setup of quarantine hospitals is prepared to match this protocol. Photo: Low reported numbers of COVID-19 in Egypt (created by the authors, and used with permission).

FACTORS THAT MAY CONTRIBUTE TO LOWER THE RATE OF INFECTION IN EGYPT

The relatively low rates of newly reported COVID-19 cases in Egypt, and the modest cumulative number of cases compared to other countries could be attributed to some country-specific factors:

TEMPERATURE AND HUMIDITY

Previous studies about the outbreak of severe acute respiratory syndrome (SARS) declared a decline in the infection rate of the disease with the warming of weather. A Korean study found that low daily temperature and low relative humidity were associated with a significant increase in the incidence of influenza [4]. Absolute humidity also had significant correlations with influenza viral survival and transmission rates [5]. Additionally, some studies reported that meteorological factors could significantly affect COVID-19 rates of infection. Moreover, the doubling time of COVID-19 positively was found to be correlated with temperature and inversely with humidity, implying that a decline in the infection progression rate will occur in spring and summer, as a 20°C increase in temperature is expected to lag the doubling time 1.8 days [6]. Egypt is known to have a hot desert climate which is generally arid all over the country. Moreover, the temperature is extremely high during the summer months, especially in Upper Egypt. By comparing the average temperature during March 2020 in Cairo and other worldwide cities with a high incidence of COVID-19 infection (Milan, Albacete, New York, and Wuhan), noticeable differences are present with higher temperatures in Cairo. Moreover, Cairo had lower humidity during the same period () [7]. What could support this theory is that the rate of infection is lower in Upper Egypt, where the higher temperature climate is encountered compared to other areas of country. Probably, the climate may have a significant impact on lowering the rate of COVID-19 infection in Egypt.
Table 1

Comparison between the weather in Cairo, Milan, Albacete, New York, and Wuhan during March 2020

CairoMilanAlbaceteNew YorkWuhan
Daytime temperature (°C)
24
14.3
16.3
9.8
14.8
Nightly temperature
11
3.8
3.3
0.8
6
Average temperature
17.5

9.8
5.3
10.4
Daily sunshine (hours)
9.1
4.9
7
7.5
4.2
Average rainfall (mm)
2.2
265
27
101.8
95.1
Rainy days
2
7
5
11
15
Humidity (%)5471636079
Comparison between the weather in Cairo, Milan, Albacete, New York, and Wuhan during March 2020

BCG VACCINE USE

Bacille Calmette-Guérin (BCG) is a live attenuated vaccine against Mycobacterium bovis (M. bovis). BCG vaccine has been shown to produce non-specific immune effects leading to enhanced response against other non-mycobacterial organisms [8]. Trained immunity is a term called to describe a proposed metabolic and epigenetic changes following BCG vaccination resulting in an advancement of genetic regions encoding for pro-inflammatory cytokines. BCG vaccination boosts the release of pro-inflammatory cytokines, specifically IL-1β, which has a potent antiviral effect [9]. Some recent studies claimed that BCG vaccination might play a role in reducing the rate of COVID-19, and rates of its related morbidity and mortality. In a recent report, countries that had never implemented universal vaccination policies (Italy, USA, and Nederland) have higher rates of COVID-19 infection and increased mortality. Countries that applied the universal BCG vaccination strategy late in the 20th century, like Iran, were also noticed to have increased rates of infection and mortality, which might be due to unprotected older population [8]. Egypt included BCG vaccination in compulsory vaccination program early since 1974. According to this theory, the relatively low rates of COVID-19 infections and mortalities in Egypt may be partially attributed to the early intake of BCG vaccination in the country. However, no available data up till now could support such a relation or explain why some countries which have never provide BCG vaccination for the population has a low rate of infection.

PREVALENT COVID-19 SUBTYPE

Two significant subtypes of SARS-CoV-2 are detected based on two Single nucleotide polymorphism (SNP). The L type was found to be derived from the S type, but L ( ~ 70%) is more prevalent than S ( ~ 30%). This suggests that L has a higher transmission rate than the S type [10]. Clinical picture and mortality rates could be correlated with the prevalent type of COVID-19. Up to date, no data are available about the epigenetics of the type of COVID-19 in Egypt. The relatively low number of cases and low case fatality in the country may suggest a less aggressive type of COVID-19.

THE EGYPTIAN SITUATION: A FUTURE POLL

The rapidly varying situation of the disease across the globe could easily make this report unsound at a particular stage, yet hopefully soon, and once the COVID-19 universal disaster is arrested, many facts for the future will be clarified. For the time being, we call for adhering to more conservative measures till reaching a downsloping curve for the number of reported cases in the country.
  6 in total

Review 1.  Influenza and humidity--Why a bit more damp may be good for you!

Authors:  Jane A Metz; Adam Finn
Journal:  J Infect       Date:  2015-04-25       Impact factor: 6.072

2.  Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study.

Authors:  Marius Gilbert; Giulia Pullano; Francesco Pinotti; Eugenio Valdano; Chiara Poletto; Pierre-Yves Boëlle; Eric D'Ortenzio; Yazdan Yazdanpanah; Serge Paul Eholie; Mathias Altmann; Bernardo Gutierrez; Moritz U G Kraemer; Vittoria Colizza
Journal:  Lancet       Date:  2020-02-20       Impact factor: 79.321

3.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

4.  Effects of temperature, humidity, and diurnal temperature range on influenza incidence in a temperate region.

Authors:  Ji-Eun Park; Woo-Sik Son; Yeonhee Ryu; Soo Beom Choi; Okyu Kwon; Insung Ahn
Journal:  Influenza Other Respir Viruses       Date:  2019-10-21       Impact factor: 4.380

5.  Estimation of the COVID-19 burden in Egypt through exported case detection.

Authors:  Ashleigh R Tuite; Victoria Ng; Erin Rees; David Fisman; Annelies Wilder-Smith; Kamran Khan; Isaac I Bogoch
Journal:  Lancet Infect Dis       Date:  2020-03-26       Impact factor: 25.071

6.  Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity.

Authors:  Johanneke Kleinnijenhuis; Jessica Quintin; Frank Preijers; Christine Stabell Benn; Leo A B Joosten; Cor Jacobs; Joke van Loenhout; Ramnik J Xavier; Peter Aaby; Jos W M van der Meer; Reinout van Crevel; Mihai G Netea
Journal:  J Innate Immun       Date:  2013-10-30       Impact factor: 7.349

  6 in total
  19 in total

1.  Impact of COVID-19 pandemic on the neurosurgical practice in Egypt.

Authors:  Mohamed Nabil; Mohammed Dorrah; Asmaa Sharfeldin; Hassan Abaza
Journal:  Egypt J Neurosurg       Date:  2022-06-07

2.  Admission Levels of Serum P-Selectin and IL-6 Can Predict Development of Deep Venous Thrombosis in Hospitalized Covid-19 Patients.

Authors:  Nehal Farouk; Walaa Mohamed Omar Ashry; Hanan A El-Hagrasy; Eman F Mohamed; Heba H Eltrawy; Asmaa M El-Nasser; Walaa Shipl; Shahinaz El Attar; Lobna Kh Sakr; Maisa A Abdel Wahab; Eman M Abdelsalam; Fawzia A Sharaf; Inass Hassan Ahmad
Journal:  Int J Gen Med       Date:  2022-06-10

3.  Risk Factors Associated with Mortality Among Patients with Novel Coronavirus Disease (COVID-19) in Africa.

Authors:  Mustapha Mohammed; Surajuddeen Muhammad; Fatima Zaji Mohammed; Sagir Mustapha; Abubakar Sha'aban; Najib Yahaya Sani; Mubarak Hussaini Ahmad; Auwal Adam Bala; Marzuq Abubakar Ungogo; Nawaf M Alotaibi; Hadzliana Zainal
Journal:  J Racial Ethn Health Disparities       Date:  2020-10-13

4.  Malaria incidence and mortality in Zimbabwe during the COVID-19 pandemic: analysis of routine surveillance data.

Authors:  Samuel Gavi; Oscar Tapera; Joseph Mberikunashe; Mufaro Kanyangarara
Journal:  Malar J       Date:  2021-05-24       Impact factor: 2.979

5.  A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa.

Authors:  Eduan Wilkinson; Marta Giovanetti; Houriiyah Tegally; James E San; Richard Lessells; Diego Cuadros; Darren P Martin; David A Rasmussen; Abdel-Rahman N Zekri; Abdoul K Sangare; Abdoul-Salam Ouedraogo; Abdul K Sesay; Abechi Priscilla; Adedotun-Sulaiman Kemi; Adewunmi M Olubusuyi; Adeyemi O O Oluwapelumi; Adnène Hammami; Adrienne A Amuri; Ahmad Sayed; Ahmed E O Ouma; Aida Elargoubi; Nnennaya A Ajayi; Ajogbasile F Victoria; Akano Kazeem; Akpede George; Alexander J Trotter; Ali A Yahaya; Alpha K Keita; Amadou Diallo; Amadou Kone; Amal Souissi; Amel Chtourou; Ana V Gutierrez; Andrew J Page; Anika Vinze; Arash Iranzadeh; Arnold Lambisia; Arshad Ismail; Audu Rosemary; Augustina Sylverken; Ayoade Femi; Azeddine Ibrahimi; Baba Marycelin; Bamidele S Oderinde; Bankole Bolajoko; Beatrice Dhaala; Belinda L Herring; Berthe-Marie Njanpop-Lafourcade; Bronwyn Kleinhans; Bronwyn McInnis; Bryan Tegomoh; Cara Brook; Catherine B Pratt; Cathrine Scheepers; Chantal G Akoua-Koffi; Charles N Agoti; Christophe Peyrefitte; Claudia Daubenberger; Collins M Morang'a; D James Nokes; Daniel G Amoako; Daniel L Bugembe; Danny Park; David Baker; Deelan Doolabh; Deogratius Ssemwanga; Derek Tshiabuila; Diarra Bassirou; Dominic S Y Amuzu; Dominique Goedhals; Donwilliams O Omuoyo; Dorcas Maruapula; Ebenezer Foster-Nyarko; Eddy K Lusamaki; Edgar Simulundu; Edidah M Ong'era; Edith N Ngabana; Edwin Shumba; Elmostafa El Fahime; Emmanuel Lokilo; Enatha Mukantwari; Eromon Philomena; Essia Belarbi; Etienne Simon-Loriere; Etilé A Anoh; Fabian Leendertz; Faida Ajili; Fakayode O Enoch; Fares Wasfi; Fatma Abdelmoula; Fausta S Mosha; Faustinos T Takawira; Fawzi Derrar; Feriel Bouzid; Folarin Onikepe; Fowotade Adeola; Francisca M Muyembe; Frank Tanser; Fred A Dratibi; Gabriel K Mbunsu; Gaetan Thilliez; Gemma L Kay; George Githinji; Gert van Zyl; Gordon A Awandare; Grit Schubert; Gugu P Maphalala; Hafaliana C Ranaivoson; Hajar Lemriss; Happi Anise; Haruka Abe; Hela H Karray; Hellen Nansumba; Hesham A Elgahzaly; Hlanai Gumbo; Ibtihel Smeti; Ikhlas B Ayed; Ikponmwosa Odia; Ilhem Boutiba Ben Boubaker; Imed Gaaloul; Inbal Gazy; Innocent Mudau; Isaac Ssewanyana; Iyaloo Konstantinus; Jean B Lekana-Douk; Jean-Claude C Makangara; Jean-Jacques M Tamfum; Jean-Michel Heraud; Jeffrey G Shaffer; Jennifer Giandhari; Jingjing Li; Jiro Yasuda; Joana Q Mends; Jocelyn Kiconco; John M Morobe; John O Gyapong; Johnson C Okolie; John T Kayiwa; Johnathan A Edwards; Jones Gyamfi; Jouali Farah; Joweria Nakaseegu; Joyce M Ngoi; Joyce Namulondo; Julia C Andeko; Julius J Lutwama; Justin O'Grady; Katherine Siddle; Kayode T Adeyemi; Kefentse A Tumedi; Khadija M Said; Kim Hae-Young; Kwabena O Duedu; Lahcen Belyamani; Lamia Fki-Berrajah; Lavanya Singh; Leonardo de O Martins; Lynn Tyers; Magalutcheemee Ramuth; Maha Mastouri; Mahjoub Aouni; Mahmoud El Hefnawi; Maitshwarelo I Matsheka; Malebogo Kebabonye; Mamadou Diop; Manel Turki; Marietou Paye; Martin M Nyaga; Mathabo Mareka; Matoke-Muhia Damaris; Maureen W Mburu; Maximillian Mpina; Mba Nwando; Michael Owusu; Michael R Wiley; Mirabeau T Youtchou; Mitoha O Ayekaba; Mohamed Abouelhoda; Mohamed G Seadawy; Mohamed K Khalifa; Mooko Sekhele; Mouna Ouadghiri; Moussa M Diagne; Mulenga Mwenda; Mushal Allam; My V T Phan; Nabil Abid; Nadia Touil; Nadine Rujeni; Najla Kharrat; Nalia Ismael; Ndongo Dia; Nedio Mabunda; Nei-Yuan Hsiao; Nelson B Silochi; Ngoy Nsenga; Nicksy Gumede; Nicola Mulder; Nnaemeka Ndodo; Norosoa H Razanajatovo; Nosamiefan Iguosadolo; Oguzie Judith; Ojide C Kingsley; Okogbenin Sylvanus; Okokhere Peter; Oladiji Femi; Olawoye Idowu; Olumade Testimony; Omoruyi E Chukwuma; Onwe E Ogah; Chika K Onwuamah; Oshomah Cyril; Ousmane Faye; Oyewale Tomori; Pascale Ondoa; Patrice Combe; Patrick Semanda; Paul E Oluniyi; Paulo Arnaldo; Peter K Quashie; Philippe Dussart; Phillip A Bester; Placide K Mbala; Reuben Ayivor-Djanie; Richard Njouom; Richard O Phillips; Richmond Gorman; Robert A Kingsley; Rosina A A Carr; Saâd El Kabbaj; Saba Gargouri; Saber Masmoudi; Safietou Sankhe; Salako B Lawal; Samar Kassim; Sameh Trabelsi; Samar Metha; Sami Kammoun; Sanaâ Lemriss; Sara H A Agwa; Sébastien Calvignac-Spencer; Stephen F Schaffner; Seydou Doumbia; Sheila M Mandanda; Sherihane Aryeetey; Shymaa S Ahmed; Siham Elhamoumi; Soafy Andriamandimby; Sobajo Tope; Sonia Lekana-Douki; Sophie Prosolek; Soumeya Ouangraoua; Steve A Mundeke; Steven Rudder; Sumir Panji; Sureshnee Pillay; Susan Engelbrecht; Susan Nabadda; Sylvie Behillil; Sylvie L Budiaki; Sylvie van der Werf; Tapfumanei Mashe; Tarik Aanniz; Thabo Mohale; Thanh Le-Viet; Tobias Schindler; Ugochukwu J Anyaneji; Ugwu Chinedu; Upasana Ramphal; Uwanibe Jessica; Uwem George; Vagner Fonseca; Vincent Enouf; Vivianne Gorova; Wael H Roshdy; William K Ampofo; Wolfgang Preiser; Wonderful T Choga; Yaw Bediako; Yeshnee Naidoo; Yvan Butera; Zaydah R de Laurent; Amadou A Sall; Ahmed Rebai; Anne von Gottberg; Bourema Kouriba; Carolyn Williamson; Daniel J Bridges; Ihekweazu Chikwe; Jinal N Bhiman; Madisa Mine; Matthew Cotten; Sikhulile Moyo; Simani Gaseitsiwe; Ngonda Saasa; Pardis C Sabeti; Pontiano Kaleebu; Yenew K Tebeje; Sofonias K Tessema; Christian Happi; John Nkengasong; Tulio de Oliveira
Journal:  Science       Date:  2021-09-09       Impact factor: 63.714

6.  Psychological Impact of COVID-19 Pandemic Among the General Population in Jordan.

Authors:  Moawiah Khatatbeh; Aws Khasawneh; Hasan Hussein; Omar Altahat; Fadwa Alhalaiqa
Journal:  Front Psychiatry       Date:  2021-04-14       Impact factor: 4.157

7.  The experiences, challenges, and acceptance of e-learning as a tool for teaching during the COVID-19 pandemic among university medical staff.

Authors:  Marwa Mohamed Zalat; Mona Sami Hamed; Sarah Abdelhalim Bolbol
Journal:  PLoS One       Date:  2021-03-26       Impact factor: 3.240

8.  The first 8 months of COVID-19 pandemic in three West African countries: leveraging lessons learned from responses to the 2014-2016 Ebola virus disease outbreak.

Authors:  Benido Impouma; George Sie Williams; Fleury Moussana; Franck Mboussou; Bridget Farham; Caitlin M Wolfe; Charles Okot; Katrina Downing; Claudia Codeço Tores; Antoine Flahault; Cyril Pervilhac; Georges Ki-Zerbo; Peter Clement; Steven Shongwe; Olivia Keiser; Ibrahima Socé Fall
Journal:  Epidemiol Infect       Date:  2021-09-08       Impact factor: 2.451

9.  Assessment of community psycho-behavioral responses during the outbreak of novel coronavirus (2019-nCoV): a cross-sectional study.

Authors:  Doaa M Magdy; Ahmed Metwally; Omar Magdy
Journal:  AIMS Public Health       Date:  2021-11-09

Review 10.  Global data analysis and risk factors associated with morbidity and mortality of COVID-19.

Authors:  Sina Salajegheh Tazerji; Fatemeh Shahabinejad; Mahya Tokasi; Mohammad Ali Rad; Muhammad Sajjad Khan; Muhammad Safdar; Krzysztof J Filipiak; Lukasz Szarpak; Tomasz Dzieciatkowski; Jan Jurgiel; Phelipe Magalhães Duarte; Md Tanvir Rahman; Md Abdus Sobur; Md Saiful Islam; Adnan Ahmed; Mohamed N F Shaheen; Awad A Shehata; Rasha Gharieb; Mohamed Fawzy; Yashpal Singh Malik; Nagaraj Jaganathasamy; Vinodhkumar Obli Rajendran; Kannan Subbaram; P Shaik Syed Ali; Sheeza Ali; Saif Ur Rehman; Mehmet Ozaslan; Gulfaraz Khan; Muhammad Saeed; Umair Younas; Safdar Imran; Yasmeen Junejo; Parmida Arabkarami; Unarose Hogan; Alfonso J Rodriguez-Morales
Journal:  Gene Rep       Date:  2022-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.